Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Muteins of human neutrophil gelatinase-associated lipocalin and related proteins

A neutrophil and mutant protein technology, applied in the field of human neutrophil gelatinase-related lipocalin and mutant proteins of related proteins

Inactive Publication Date: 2007-07-11
PIERIS AG
View PDF7 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Although anticalin  The technology is largely established and may lead to promising practical applications in digoxigenin binding to Bbp muteins as described above, but other improvements and practical applications are still needed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
  • Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
  • Muteins of human neutrophil gelatinase-associated lipocalin and related proteins

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0109] Example 1: Preparation of hNGAL mutant protein library

[0110] Unless otherwise indicated, genetic engineering methods known to those skilled in the art, such as those described by Sambrook et al. (supra) were used.

[0111] PCR was used in multiple steps according to Figure 2 to allow for concerted mutagenesis at all 20 selected amino acid positions in the four peptide loops of hNGAL. A PCR reaction of 100 μl volume was carried out in both first amplification steps, wherein 20 ng of phNGAL3 plasmid DNA was used as a template, and 50 pmol each of the corresponding primers (respectively SEQ ID NO: 1 and SEQ ID NO: 2 or SEQ ID NO: 1 and SEQ ID NO: 2 or SEQ ID NO: NO: 3 and SEQ ID NO: 4), these primers were synthesized by the traditional phosphoramidite method. Additionally, the reaction mixture contained 10 μl of 10xFaq buffer (100 mM Tris / HCl pH 9.0, 500 mM KCl, 15 mM MgCl 2 , 1% (v / v) Triton X-100), 10 μl dNTP mix (2 mM dATP, dCTP, dGTP, dTTP). After adding water ...

Embodiment 2

[0117] Example 2: Phagemid presentation and screening of hNGAL mutant proteins against human Tear lipocarin.

[0118] 200 ml of a culture containing cells transformed with a plasmid vector similar to phNGAL5 but encoding a library of lipocalin muteins as fusion proteins was transferred into sterile Erlenmeyer flasks. After infection with VCS-M13 helper phage (Stratagene) at a multiplicity of infection of about 10, the culture was then shaken at 160 rpm for 30 minutes at 37°C. Kanamycin (70 μg / ml) was then added, the temperature of the incubator was lowered to 30°C, and anhydrotetracycline (200 μl of a 100 μg / ml stock solution in dimethylformamide (DMF)) was added to 100 μg / L after 10 minutes. to induce gene expression. The incubation was continued for another 5 hours at 30°C, 160 rpm.

[0119] From this culture, 50 ml were taken and the cells were pelleted by centrifugation (15 min, 12000 g, 4°C). The supernatant containing phagemid particles was sterile filtered (0.45 μm...

Embodiment 3

[0128] Embodiment 3: Use " colony screening " method to identify the hNGAL combined with human Tear fat cardin mutein

[0129] In order to produce hNGAL muteins with Strep-Tag(R) II and the albumin binding domain as fusion proteins for analysis and to identify them by colony screening, the gene cassette between the two BstXI cleavage sites was extracted from the vector phNGAL5 Subcloned into phNGAL7.

[0130] For this purpose, plasmid DNA was isolated using the Perfectprep Plasmid Midi Kit (Eppendorf) from the E. coli cloning mixture obtained by infection with phagemids from Example 2 eluted as a result of the final selection round. The DNA was cut with restriction enzyme BstXI, and the smaller of the two fragments (347 bp) was purified by preparative agarose gel electrophoresis as described in Example 1. The DNA of vector phNGAL7 was cut with BstXI and the larger of the two fragments (3971bp) was isolated in the same way.

[0131] For ligation, 100 fmol each of the two ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
Login to View More

Abstract

Disclosed is a method for generating a mutein of a protein selected from the group consisting of human neutrophil gelatinase-associated lipocalin (hNGAL), rat alpha 2- microglobulin-related protein (A2m) and mouse 24p3 / uterocalin (24p3), said mutein having detectable affinity to a given target. The method comprises the step of subjecting the protein to mutagenesis at one or more of the sequence positions which correspond to the sequence positions 33 to 54, 66 to 83, 94 to 106, and 123 to 136 of hNGAL, resulting in one or more mutein(s) of the protein. Also disclosed are muteins obtainable by this method.

Description

technical field [0001] The invention relates to the preparation of human neutrophil gelatinase related lipocalin (lipocalin) (hNGAL), rat α 2 -A method for a mutein of microglobulin-associated protein (A2m) or mouse 24p3 / uterocalin (uterocalin) (24p3), wherein the mutein has a detectable affinity for a given target and involves Mutant proteins of these three proteins were obtained. The present invention also relates to nucleic acids encoding these mutant proteins, pharmaceutical compositions containing the mutant proteins of the present invention, human neutrophil gelatinase-associated lipocarin, rat α 2 - Various uses of the muteins of microglobulin-associated protein (A2m) and mouse 24p3 / utecarin (24p3). Background of the invention [0002] Lipocarins (Pervaiz and Brew, FASEB J.1 (1987), 209-214) are a family of small, often monomeric, secreted proteins that have been isolated from various organisms and whose physiological Act to store or transport different target subs...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/12C07K14/47C12N15/62A61K38/17G01N33/68A61P13/08C12N15/09A61K38/00A61P43/00C07K19/00C12P21/02
CPCC07K2319/00C07K14/47A61P13/08A61P43/00
Inventor A·斯克拉S·施勒胡伯尔
Owner PIERIS AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products